{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:14:06Z","timestamp":1786468446802,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.drugalcdep.2020.108220","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T19:06:28Z","timestamp":1596308788000},"page":"108220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial"],"prefix":"10.1016","volume":"215","author":[{"given":"Nicholas","family":"Lintzeris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llewellyn","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Mcgregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Montebello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108220_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiat"},{"key":"10.1016\/j.drugalcdep.2020.108220_bib0010","article-title":"Methadone at tapered doses for the management of opioid withdrawal","author":"Amato","year":"2013","journal-title":"Cochrane DB Syst. Rev"},{"key":"10.1016\/j.drugalcdep.2020.108220_bib0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drugalcdep.2018.03.017","article-title":"Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials","volume":"187","author":"Baker","year":"2018","journal-title":"Drug Alcohol. Depen."},{"key":"10.1016\/j.drugalcdep.2020.108220_bib0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","author":"Benjamini","year":"1995","journal-title":"J. Roy Stat. Soc. B Met."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12888-018-1682-2","article-title":"Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol","volume":"18","author":"Bhardwaj","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/npp.2017.212","article-title":"The current state of pharmacological treatments for Cannabis use disorder and withdrawal","volume":"43","author":"Brezing","year":"2017","journal-title":"Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms","volume":"86","author":"Budney","year":"2007","journal-title":"Drug Alcohol. Depen."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108220_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/16066359.2015.1073719","article-title":"Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review","volume":"24","author":"Chatters","year":"2016","journal-title":"Addict. Res. Theory"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108220_bib0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.psc.2012.03.003","article-title":"State of the art treatments for cannabis dependence","volume":"35","author":"Danovitch","year":"2012","journal-title":"Psychiat. Clin. N Am."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsat.2010.08.007","article-title":"Outpatient versus inpatient opioid detoxification: a randomized controlled trial","volume":"40","author":"Day","year":"2011","journal-title":"J. Subs Abuse Treat"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108220_bib0055","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"issue":"42","key":"10.1016\/j.drugalcdep.2020.108220_bib0060","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.2174\/1381612822666160822150822","article-title":"Pharmacological treatment of cannabis-related disorders: a narrative review","volume":"22","author":"Gorelick","year":"2016","journal-title":"Curr. Pharm. Design"},{"issue":"10173","key":"10.1016\/j.drugalcdep.2020.108220_bib0065","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(18)32259-1","article-title":"Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"393","author":"Haight","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.npp.1300310","article-title":"Marijuana withdrawal in humans: effects of oral THC or divalproex","volume":"29","author":"Haney","year":"2003","journal-title":"Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108220_bib0075","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/npp.2013.54","article-title":"Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse","volume":"38","author":"Haney","year":"2013","journal-title":"Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108220_bib0080","article-title":"Nicotine replacement therapy versus control for smoking cessation","volume":"5","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane DB Syst. Rev."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11419-016-0330-0","article-title":"Urinary cannabinoid levels during nabiximols (Sativex\u00ae)-medicated inpatient cannabis withdrawal","volume":"35","author":"Kevin","year":"2017","journal-title":"Forensic Toxicoy."},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108220_bib0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2215-0366(15)00366-1","article-title":"Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study","volume":"2","author":"Kimber","year":"2015","journal-title":"The Lancet Psychiat."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108220_bib0095","first-page":"293","article-title":"Smoking reduction and temporary abstinence: new approaches for smoking cessation","volume":"28","author":"Le","year":"2003","journal-title":"J. Mal. Vasc."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2010.12.010","article-title":"Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial","volume":"116","author":"Levin","year":"2011","journal-title":"Drug Alcohol. Depen."},{"key":"10.1016\/j.drugalcdep.2020.108220_bib0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugalcdep.2015.11.025","article-title":"Dronabinol and lofexidine for cannabis use disorder: a randomized, double-blind, placebo-controlled trial","volume":"159","author":"Levin","year":"2016","journal-title":"Drug Alcohol. Depen."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108220_bib0110","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamainternmed.2019.1993","article-title":"Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial","volume":"179","author":"Lintzeris","year":"2019","journal-title":"JAMA Intern. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108220_bib0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/dar.12440","article-title":"Community detoxification for alcohol dependence: a systematic review","volume":"36","author":"Nadkarni","year":"2017","journal-title":"Drug Alcohol Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108220_bib0120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1037\/0022-006X.65.2.252","article-title":"Now you see it, now you don\u2019t: a comparison of traditional versus random-effects regression models in the analysis of longitudinal follow-up data from a clinical trial","volume":"65","author":"Nich","year":"1997","journal-title":"J. Consult. Clin. Psych."},{"key":"10.1016\/j.drugalcdep.2020.108220_bib0125","first-page":"1","article-title":"Pharmacotherapies for cannabis dependence","author":"Nielsen","year":"2019","journal-title":"Cochrane DB Syst. Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108220_bib0130","first-page":"163","article-title":"Psychosocial and pharmacological interventions for the treatment of Cannabis use disorder","volume":"17","author":"Sabioni","year":"2019","journal-title":"FOCUS, A J. Am. Psychiatr. Assoc."},{"key":"10.1016\/j.drugalcdep.2020.108220_bib0135","series-title":"Timeline follow-back. In Measuring Alcohol Consumption","first-page":"41","author":"Sobell","year":"1992"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0140","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1038\/s41598-018-28127-0","article-title":"Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community","volume":"8","author":"Suraev","year":"2018","journal-title":"Sci Rep-UK"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190768","article-title":"Nabiximols combined with motivational enhancement\/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial","volume":"13","author":"Trigo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2020.108220_bib0150","series-title":"World Drug Report 2015. Vienna: UN Office on Drugs and Crime (UNODC)","author":"UNODC","year":"2015"},{"issue":"23","key":"10.1016\/j.drugalcdep.2020.108220_bib0155","first-page":"2219","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"New England J. Med. Surg. Collat. Branches Sci."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108220_bib0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1467-9531.2007.00180.x","article-title":"4. Regression with missing ys: an improved strategy for analyzing multiply imputed data","volume":"37","author":"Von Hippel","year":"2007","journal-title":"Sociol. Methodol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:05:05Z","timestamp":1759827905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620303859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":32,"alternative-id":["S0376871620303859"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108220","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108220"}}